CPC A61K 39/12 (2013.01) [A61K 35/76 (2013.01); A61K 39/39 (2013.01); A61P 35/00 (2018.01); A61K 2039/53 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/585 (2013.01)] | 10 Claims |
1. A DNA vaccine, comprising:
a DNA construct comprising a fusion gene,
wherein the fusion gene includes an optimized human papillomavirus (HPV) subsequence encoding at least one HPV antigen, and
wherein the optimized HPV subsequence comprises one or more of:
an HPV-16 E6 expressing gene set forth in SEQ ID NO: 1,
an HPV-16 E7 expressing gene set forth in SEQ ID NO: 2,
an HPV-18 E6 expressing gene set forth in SEQ ID NO: 3, and
an HPV-18 E7 expressing gene set forth in SEQ ID NO: 4.
|